Concepedia

Kishan R. Chandupatla

KR

Statistics

Publications

6

Citations

225

H-Index

6

Active since

2001

Affiliations

Clemson University(Current)

Vertex Pharmaceuticals (United States)

Vertex Pharmaceuticals (Canada)

Kishan R. Chandupatla is an author at Clemson University specializing in medicinal chemistry, enzyme inhibition, and pharmacy.

Publications per year

2001–2021

6

Publications

6

Reactivity and Enantioselectivity in the Reactions of Scalemic Stereogenic α-(<i>N</i>-Carbamoyl)alkylcuprates

R. Karl Dieter, Gabriel Oba, Kishan R. Chandupatla et al. · The Journal of Organic Chemistry · 2004 · 73 citations

, , +8

Enantioselectivity in the Reactions of Chiral α-(<i>N</i>-Carbamoyl)alkylcuprates

R. Karl Dieter, Chris M. Topping, Kishan R. Chandupatla et al. · Journal of the American Chemical Society · 2001 · 69 citations

, , +6

Synthesis of (−)-(<i>R</i>)-Pyrrolam A and Studies on Its Stability:  A Caveat on Computational Methods

Rhett T. Watson, Vinayak K. Gore, Kishan R. Chandupatla et al. · The Journal of Organic Chemistry · 2004 · 32 citations

, , +12

Discovery and Characterization of a Water-Soluble Prodrug of a Dual Inhibitor of Bacterial DNA Gyrase and Topoisomerase IV

Hardwin O’Dowd, Dean Shannon, Kishan R. Chandupatla et al. · ACS Medicinal Chemistry Letters · 2015 · 21 citations · Full text

, , +17

Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1

Michael J. Boyd, Philip N. Collier, Michael P. Clark et al. · Journal of Medicinal Chemistry · 2021 · 18 citations · Full text

, , +14

1–5 of 6